A share price of Abbvie Inc [ABBV] is currently trading at $213.0, up 0.54%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ABBV shares have gain 2.37% over the last week, with a monthly amount glided 7.28%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Daiwa Securities upgraded its rating to Outperform on August 07, 2025, and kept the price target unchanged to $214. On May 14, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $205 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $210 on April 22, 2025. Daiwa Securities downgraded its rating to Neutral for this stock on December 05, 2024, but kept the price target unchanged to $180. In a note dated November 22, 2024, Leerink Partners upgraded an Outperform rating on this stock but restated the target price of $206.
Abbvie Inc experienced fluctuations in its stock price throughout the past year between $163.81 and $218.66. Currently, Wall Street analysts expect the stock to reach $173.96 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $213.0 at the most recent close of the market. An investor can expect a potential drop of -18.33% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
Trailing Twelve Months sales for Abbvie Inc [NYSE:ABBV] were 58.33B which represents 6.65% growth. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.2%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.86 and Total Capital is 0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of49.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 211.71 points at the first support level, and at 210.42 for the second support level. However, for the 1st resistance point, the stock is sitting at 214.24, and for the 2nd resistance point, it is at 215.48.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Abbvie Inc [NYSE:ABBV] is 0.74. In addition, the Quick Ratio stands at 0.61 and the Cash Ratio stands at 0.14. Considering the valuation of this stock, the price to sales ratio is 6.45 and price to earnings (TTM) ratio is 101.37.
Transactions by insiders
Recent insider trading involved Richard A. Gonzalez, Former Director, that happened on Aug 22 ’25 when 62755.0 shares were purchased. Former Director, Richard A. Gonzalez completed a deal on Aug 21 ’25 to buy 90000.0 shares. Meanwhile, EVP, CHIEF OPERATIONS OFFICER SALEKI-GERHARDT AZITA sold 42370.0 shares on Aug 12 ’25.
